{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T15:28:18Z","timestamp":1784302098895,"version":"3.55.0"},"reference-count":36,"publisher":"American Association for Cancer Research (AACR)","issue":"5","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Purpose: Programmed death ligand-1 (PD-L1), encoded by the CD274 gene, is a target for immune checkpoint blockade; however, little is known about genomic CD274 alterations. A subset of small-cell lung cancer (SCLC) exhibits increased copy number of chromosome 9p24, on which CD274 resides; however, most SCLCs show low expression of PD-L1. We therefore examined whether CD274 is a target of recurrent genomic alterations.<\/jats:p>\n                  <jats:p>Experimental Design: We examined somatic copy number alterations in two patient cohorts by quantitative real-time PCR in 72 human SCLC cases (cohort 1) and SNP array analysis in 138 human SCLC cases (cohort 2). Whole-genome sequencing revealed the detailed genomic structure underlying focal amplification. PD-L1 expression in amplified cases from cohorts 1 and 2 was further examined by transcriptome sequencing and immunohistochemical (IHC) staining.<\/jats:p>\n                  <jats:p>Results: By examining somatic copy number alterations in two cohorts of primary human SCLC specimens, we observed 9p24 copy number gains (where CD274 resides) and focal, high-level amplification of CD274. We found evidence for genomic targeting of CD274, suggesting selection during oncogenic transformation. CD274 amplification was caused by genomic rearrangements not affecting the open reading frame, thus leading to massively increased CD274 transcripts and high level expression of PD-L1.<\/jats:p>\n                  <jats:p>Conclusions: A subset (4\/210, 1.9%) of human SCLC patient cases exhibits massive expression of PD-L1 caused by focal amplification of CD274. Such tumors may be particularly susceptible to immune checkpoint blockade. Clin Cancer Res; 23(5); 1220\u20136. \u00a92016 AACR.<\/jats:p>","DOI":"10.1158\/1078-0432.ccr-16-1069","type":"journal-article","created":{"date-parts":[[2016,9,12]],"date-time":"2016-09-12T22:28:59Z","timestamp":1473719339000},"page":"1220-1226","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":93,"title":["Genomic Amplification of\n                    <i>CD274<\/i>\n                    (PD-L1) in Small-Cell Lung Cancer"],"prefix":"10.1158","volume":"23","author":[{"given":"Julie","family":"George","sequence":"first","affiliation":[{"name":"1Department of Translational Genomics, Center of Integrated Oncology Cologne-Bonn, Medical Faculty, University of Cologne, Cologne, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motonobu","family":"Saito","sequence":"additional","affiliation":[{"name":"2Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan."},{"name":"3Department of Organ Regulatory Surgery, Fukushima Medical University School of Medicine, Fukushima, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Tsuta","sequence":"additional","affiliation":[{"name":"4Division of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reika","family":"Iwakawa","sequence":"additional","affiliation":[{"name":"2Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouya","family":"Shiraishi","sequence":"additional","affiliation":[{"name":"2Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas H.","family":"Scheel","sequence":"additional","affiliation":[{"name":"5Institute of Pathology, University Hospital Cologne, Cologne, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Uchida","sequence":"additional","affiliation":[{"name":"4Division of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun-ichi","family":"Watanabe","sequence":"additional","affiliation":[{"name":"6Division of Thoracic Surgery, National Cancer Center Hospital, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Nishikawa","sequence":"additional","affiliation":[{"name":"7Department of Neuro-Oncology\/Neurosurgery, Saitama Medical University International Medical Center, Saitama, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Noguchi","sequence":"additional","affiliation":[{"name":"8Department of Pathology, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Peifer","sequence":"additional","affiliation":[{"name":"9Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Jin","family":"Jang","sequence":"additional","affiliation":[{"name":"10Center for Cancer Genome Discovery, Asan Institute for Life Science, Asan Medical Center, Seoul, Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iver","family":"Petersen","sequence":"additional","affiliation":[{"name":"11Institute of Pathology, Jena University Hospital, Friedrich-Schiller-University, Jena, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"B\u00fcttner","sequence":"additional","affiliation":[{"name":"5Institute of Pathology, University Hospital Cologne, Cologne, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curtis C.","family":"Harris","sequence":"additional","affiliation":[{"name":"12Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yokota","sequence":"additional","affiliation":[{"name":"2Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan."},{"name":"13Cancer Genome Biology Group, Institute of Predictive and Personalized Medicine of Cancer, Barcelona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman K.","family":"Thomas","sequence":"additional","affiliation":[{"name":"1Department of Translational Genomics, Center of Integrated Oncology Cologne-Bonn, Medical Faculty, University of Cologne, Cologne, Germany."},{"name":"5Institute of Pathology, University Hospital Cologne, Cologne, Germany."},{"name":"14German Cancer Research Center, German Cancer Consortium (DKTK), Heidelberg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kohno","sequence":"additional","affiliation":[{"name":"2Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan."},{"name":"15Division of Translational Research Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2017,2,28]]},"reference":[{"key":"2022061102444460800_bib1","doi-asserted-by":"crossref","first-page":"4539","DOI":"10.1200\/JCO.2005.04.4859","article-title":"Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database","volume":"24","author":"Govindan","year":"2006","journal-title":"J Clin Oncol"},{"key":"2022061102444460800_bib2","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrclinonc.2011.90","article-title":"Novel strategies for the treatment of small-cell lung carcinoma","volume":"8","author":"William","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"key":"2022061102444460800_bib3","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nature13954","article-title":"PD-1 blockade induces responses by inhibiting adaptive immune resistance","volume":"515","author":"Tumeh","year":"2014","journal-title":"Nature"},{"key":"2022061102444460800_bib4","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1200\/JCO.2014.59.4358","article-title":"Immune checkpoint blockade in cancer therapy","volume":"33","author":"Postow","year":"2015","journal-title":"J Clin Oncol"},{"key":"2022061102444460800_bib5","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1411087","article-title":"PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma","volume":"372","author":"Ansell","year":"2015","journal-title":"N Engl J Med"},{"key":"2022061102444460800_bib6","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","article-title":"Safety and activity of anti-PD-L1 antibody in patients with advanced cancer","volume":"366","author":"Brahmer","year":"2012","journal-title":"N Engl J Med"},{"key":"2022061102444460800_bib7","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N Engl J Med"},{"key":"2022061102444460800_bib8","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1056\/NEJMoa1501824","article-title":"Pembrolizumab for the treatment of non-small-cell lung cancer","volume":"372","author":"Garon","year":"2015","journal-title":"N Engl J Med"},{"key":"2022061102444460800_bib9","doi-asserted-by":"crossref","first-page":"S633","DOI":"10.1016\/S0959-8049(16)31739-7","article-title":"Nivolumab (NIVO) monotherapy or in combination with ipilimumab (IPI) for treatment of recurrent small cell lung cancer (SCLC)","volume":"51","author":"Calvo","year":"2015","journal-title":"Eur J Cancer"},{"key":"2022061102444460800_bib10","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2015.33.15_suppl.7502","article-title":"Pembrolizumab (MK-3475) in patients (pts) with extensive-stage small cell lung cancer (SCLC): preliminary safety and efficacy results from KEYNOTE-028","author":"Ott","year":"2015","journal-title":"J Clin"},{"key":"2022061102444460800_bib11","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ccell.2015.03.001","article-title":"Immune checkpoint blockade: a common denominator approach to cancer therapy","volume":"27","author":"Topalian","year":"2015","journal-title":"Cancer Cell"},{"key":"2022061102444460800_bib12","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1158\/1078-0432.CCR-13-3271","article-title":"Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy","volume":"20","author":"Taube","year":"2014","journal-title":"Clin Cancer Res"},{"key":"2022061102444460800_bib13","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1126\/science.aaa1348","article-title":"Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non\u2013small cell lung cancer","volume":"348","author":"Rizvi","year":"2015","journal-title":"Science"},{"key":"2022061102444460800_bib14","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ejca.2014.12.006","article-title":"PD-L1 expression in small cell neuroendocrine carcinomas","volume":"51","author":"Schultheis","year":"2015","journal-title":"Eur J Cancer"},{"key":"2022061102444460800_bib15","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/JTO.0000000000000414","article-title":"Significance of programmed cell death-ligand 1 expression and its association with survival in patients with small cell lung cancer","volume":"10","author":"Ishii","year":"2015","journal-title":"J Thorac Oncol"},{"key":"2022061102444460800_bib16","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/j.ejca.2015.06.003","article-title":"PD-L1 expression in small cell lung cancer","volume":"51","author":"Komiya","year":"2015","journal-title":"Eur J Cancer"},{"key":"2022061102444460800_bib17","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/gcc.22076","article-title":"Genome-wide identification of genes with amplification and\/or fusion in small cell lung cancer","volume":"52","author":"Iwakawa","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"key":"2022061102444460800_bib18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature14664","article-title":"Comprehensive genomic profiles of small cell lung cancer","volume":"524","author":"George","year":"2015","journal-title":"Nature"},{"key":"2022061102444460800_bib19","doi-asserted-by":"crossref","first-page":"R41","DOI":"10.1186\/gb-2011-12-4-r41","article-title":"GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers","volume":"12","author":"Mermel","year":"2011","journal-title":"Genome Biol"},{"key":"2022061102444460800_bib20","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.lungcan.2015.03.003","article-title":"Immunohistochemical status of PD-L1 in thymoma and thymic carcinoma","volume":"88","author":"Katsuya","year":"2015","journal-title":"Lung Cancer"},{"key":"2022061102444460800_bib21","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/ng.2396","article-title":"Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer","volume":"44","author":"Peifer","year":"2012","journal-title":"Nat Genet"},{"key":"2022061102444460800_bib22","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/ng.2405","article-title":"Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer","volume":"44","author":"Rudin","year":"2012","journal-title":"Nat Genet"},{"key":"2022061102444460800_bib23","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/carcin\/bgv026","article-title":"Expression and clinical significance of genes frequently mutated in small cell lung cancers defined by whole exome\/RNA sequencing","volume":"36","author":"Iwakawa","year":"2015","journal-title":"Carcinogenesis"},{"key":"2022061102444460800_bib24","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1101\/gad.2046711","article-title":"Nuclear factor I\/B is an oncogene in small cell lung cancer","volume":"25","author":"Dooley","year":"2011","journal-title":"Genes Dev"},{"key":"2022061102444460800_bib25","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nm.2673","article-title":"Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies","volume":"18","author":"Lipson","year":"2012","journal-title":"Nat Med"},{"key":"2022061102444460800_bib26","doi-asserted-by":"crossref","first-page":"e61602","DOI":"10.1371\/journal.pone.0061602","article-title":"NF-kappaB plays a key role in inducing CD274 expression in human monocytes after lipopolysaccharide treatment","volume":"8","author":"Huang","year":"2013","journal-title":"PLoS One"},{"key":"2022061102444460800_bib27","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature14292","article-title":"Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer","volume":"520","author":"Twyman-Saints Victor","year":"2015","journal-title":"Nature"},{"key":"2022061102444460800_bib28","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1158\/2326-6066.CIR-14-0133","article-title":"PD-L1 expression correlates with tumor-infiltrating lymphocytes and response to neoadjuvant chemotherapy in breast cancer","volume":"3","author":"Wimberly","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"2022061102444460800_bib29","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature13385","article-title":"Comprehensive molecular profiling of lung adenocarcinoma","volume":"511","author":"Cancer Genome Atlas Research Network","year":"2014","journal-title":"Nature"},{"key":"2022061102444460800_bib30","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature11404","article-title":"Comprehensive genomic characterization of squamous cell lung cancers","volume":"489","author":"Cancer Genome Atlas Research Network","year":"2012","journal-title":"Nature"},{"key":"2022061102444460800_bib31","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature12222","article-title":"Comprehensive molecular characterization of clear cell renal cell carcinoma","volume":"499","author":"Cancer Genome Atlas Research Network","year":"2013","journal-title":"Nature"},{"key":"2022061102444460800_bib32","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Cancer Genome Atlas Research Network","year":"2013","journal-title":"Nature"},{"key":"2022061102444460800_bib33","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nature13480","article-title":"Comprehensive molecular characterization of gastric adenocarcinoma","volume":"513","author":"Cancer Genome Atlas Research Network","year":"2014","journal-title":"Nature"},{"key":"2022061102444460800_bib34","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nature11412","article-title":"Comprehensive molecular portraits of human breast tumours","volume":"490","author":"Cancer Genome Atlas Network","year":"2012","journal-title":"Nature"},{"key":"2022061102444460800_bib35","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/gcc.22365","article-title":"Pan-cancer analysis of copy number changes in programmed death-ligand 1 (PD-L1, CD274) - associations with gene expression, mutational load, and survival","volume":"55","author":"Budczies","year":"2016","journal-title":"Genes Chromosomes Cancer"},{"key":"2022061102444460800_bib36","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0093-7754(01)90072-7","article-title":"Molecular genetics of small cell lung carcinoma","volume":"28","author":"Wistuba","year":"2001","journal-title":"Semin Oncol"}],"container-title":["Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/clincancerres\/article-pdf\/23\/5\/1220\/1930725\/1220.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/clincancerres\/article-pdf\/23\/5\/1220\/1930725\/1220.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T11:50:32Z","timestamp":1654948232000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/clincancerres\/article\/23\/5\/1220\/122898\/Genomic-Amplification-of-CD274-PD-L1-in-Small-Cell"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,28]]},"references-count":36,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,2,28]]},"published-print":{"date-parts":[[2017,3,1]]}},"URL":"https:\/\/doi.org\/10.1158\/1078-0432.ccr-16-1069","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/1078-0432.22466897","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22466912","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22466900","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22466924","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22466924.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22466918","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22466906","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.c.6526469","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22466921.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22466915.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22466909.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22466912.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22466888.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22466891","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22466918.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22466921","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22466903.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22466888","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22466903","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22466900.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22466915","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22466906.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22466909","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22466894.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.c.6526469.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22466891.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22466897.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1078-0432.22466894","asserted-by":"object"}]},"ISSN":["1078-0432","1557-3265"],"issn-type":[{"value":"1078-0432","type":"print"},{"value":"1557-3265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,28]]}}}